1-10 of 10
Vivek Subbiah
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Vision for Democratizing Next-Generation Oncology Clinical Trials

Vivek Subbiah, Denis Horgan, Ishwaria M. Subbiah
Journal: Cancer Discovery
Cancer Discov (2024) 14 (4): 579–584.
https://doi.org/10.1158/2159-8290.CD-24-0017
Published: 04 April 2024
View articletitled, A Vision for Democratizing Next-Generation Oncology Clinical Trials
Open the PDF for A Vision for Democratizing Next-Generation Oncology Clinical Trials in another window
Journal Articles

RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across FGFR2 Alterations and Resistance Mutations

Vivek Subbiah, Vaibhav Sahai, Dejan Maglic, Kamil Bruderek, B. Barry Touré, Songping Zhao, Roberto Valverde, Patrick J. O'Hearn, Demetri T. Moustakas, Heike Schönherr, Nastaran Gerami-Moayed, Alexander M. Taylor, Brandi M. Hudson, Damian J. Houde, Debjani Pal, Lindsey Foster, Hakan Gunaydin, Pelin Ayaz, Dina A. Sharon, Lipika Goyal, Alison M. Schram, Suneel Kamath, Cori Ann Sherwin, Oleg Schmidt-Kittler, Kai Yu Jen, Fabien Ricard, Beni B. Wolf, David E. Shaw, Donald A. Bergstrom, James Watters, Jessica B. Casaletto
Journal: Cancer Discovery
Cancer Discov (2023) 13 (9): 2012–2031.
https://doi.org/10.1158/2159-8290.CD-23-0475
Published: 06 September 2023
View articletitled, RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across FGFR2 Alterations and Resistance Mutations
Open the PDF for RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across FGFR2 Alterations and Resistance Mutations in another window
Includes: Multimedia, Supplementary data
Journal Articles

N-of-1 Trials in Cancer Drug Development

Mohamed A. Gouda, Lars Buschhorn, Andreas Schneeweiss, Adam Wahida, Vivek Subbiah
Journal: Cancer Discovery
Cancer Discov (2023) 13 (6): 1301–1309.
https://doi.org/10.1158/2159-8290.CD-22-1377
Published: 02 June 2023
View articletitled, N-of-1 Trials in Cancer Drug Development
Open the PDF for N-of-1 Trials in Cancer Drug Development in another window
Journal Articles

The (R)evolution of Social Media in Oncology: Engage, Enlighten, and Encourage

Gilberto Morgan, Neeraj Agarwal, Toni K. Choueiri, Don S. Dizon, Erika P. Hamilton, Merry Jennifer Markham, Mark Lewis, Tatiana M. Prowell, Hope S. Rugo, Vivek Subbiah, Howard L. West
Journal: Cancer Discovery
Cancer Discov (2022) 12 (7): 1620–1624.
https://doi.org/10.1158/2159-8290.CD-22-0346
Published: 06 July 2022
View articletitled, The (R)evolution of Social Media in Oncology: Engage, Enlighten, and Encourage
Open the PDF for The (R)evolution of Social Media in Oncology: Engage, Enlighten, and Encourage in another window
Journal Articles

Think Globally, Act Locally: Globalizing Precision Oncology

Justin T. Moyers, Vivek Subbiah
Journal: Cancer Discovery
Cancer Discov (2022) 12 (4): 886–888.
https://doi.org/10.1158/2159-8290.CD-22-0024
Published: 01 April 2022
View articletitled, Think Globally, Act Locally: Globalizing Precision Oncology
Open the PDF for Think Globally, Act Locally: Globalizing Precision Oncology in another window
Journal Articles

Pan-Cancer Efficacy of Vemurafenib in BRAFV600-Mutant Non-Melanoma Cancers

Vivek Subbiah, Igor Puzanov, Jean-Yves Blay, Ian Chau, A. Craig Lockhart, Noopur S. Raje, Juergen Wolf, José Baselga, Funda Meric-Bernstam, Jason Roszik, Eli L. Diamond, Gregory J. Riely, Eric J. Sherman, Todd Riehl, Bethany Pitcher, David M. Hyman
Journal: Cancer Discovery
Series: Author Choice
Cancer Discov (2020) 10 (5): 657–663.
https://doi.org/10.1158/2159-8290.CD-19-1265
Published: 01 May 2020
View articletitled, Pan-Cancer Efficacy of Vemurafenib in BRAFV600-Mutant Non-Melanoma Cancers
Open the PDF for Pan-Cancer Efficacy of Vemurafenib in BRAFV600-Mutant Non-Melanoma Cancers in another window
Includes: Supplementary data
Journal Articles

Advances in Targeting RET-Dependent Cancers

Vivek Subbiah, Gilbert J. Cote
Journal: Cancer Discovery
Cancer Discov (2020) 10 (4): 498–505.
https://doi.org/10.1158/2159-8290.CD-19-1116
Published: 01 April 2020
View articletitled, Advances in Targeting RET-Dependent Cancers
Open the PDF for Advances in Targeting RET-Dependent Cancers in another window
Journal Articles

Precision Oncology for Hepatocellular Cancer: Slivering the Liver by FGF19–FGFR4–KLB Pathway Inhibition

Vivek Subbiah, Sumanta K. Pal
Journal: Cancer Discovery
Cancer Discov (2019) 9 (12): 1646–1649.
https://doi.org/10.1158/2159-8290.CD-19-1156
Published: 02 December 2019
View articletitled, Precision Oncology for Hepatocellular Cancer: Slivering the Liver by FGF19–FGFR4–KLB Pathway Inhibition
Open the PDF for Precision Oncology for Hepatocellular Cancer: Slivering the Liver by FGF19–FGFR4–KLB Pathway Inhibition in another window
Journal Articles

Precision Targeted Therapy with BLU-667 for RET-Driven Cancers

Vivek Subbiah, Justin F. Gainor, Rami Rahal, Jason D. Brubaker, Joseph L. Kim, Michelle Maynard, Wei Hu, Qiongfang Cao, Michael P. Sheets, Douglas Wilson, Kevin J. Wilson, Lucian DiPietro, Paul Fleming, Michael Palmer, Mimi I. Hu, Lori Wirth, Marcia S. Brose, Sai-Hong Ignatius Ou, Matthew Taylor, Elena Garralda, Stephen Miller, Beni Wolf, Christoph Lengauer, Timothy Guzi, Erica K. Evans
Journal: Cancer Discovery
Series: Author Choice
Cancer Discov (2018) 8 (7): 836–849.
https://doi.org/10.1158/2159-8290.CD-18-0338
Published: 01 July 2018
View articletitled, Precision Targeted Therapy with BLU-667 for RET-Driven Cancers
Open the PDF for Precision Targeted Therapy with BLU-667 for RET-Driven Cancers in another window
Includes: Supplementary data
Journal Articles

Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E Mutation

David S. Hong, Van K. Morris, Badi El Osta, Alexey V. Sorokin, Filip Janku, Siqing Fu, Michael J. Overman, Sarina Piha-Paul, Vivek Subbiah, Bryan Kee, Apostolia M. Tsimberidou, David Fogelman, Jorge Bellido, Imad Shureiqi, Helen Huang, Johnique Atkins, Gabi Tarcic, Nicolas Sommer, Richard Lanman, Funda Meric-Bernstam, Scott Kopetz
Journal: Cancer Discovery
Series: Author Choice
Cancer Discov (2016) 6 (12): 1352–1365.
https://doi.org/10.1158/2159-8290.CD-16-0050
Published: 04 December 2016
View articletitled, Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E Mutation
Open the PDF for Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E Mutation in another window
Includes: Supplementary data